New Agreements Underscore QIAGEN’s Leadership in Bioinformatics
HILDEN, Germany and AARHUS, Denmark, February 2, 2016 /PRNewswire/ — QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced new partnerships to enhance the profile and expand the use of its market leading bioinformatics solutions for microbiome, metagenomics and other applications. QIAGEN Bioinformatics signed an agreement with genomics big data company CosmosID, Inc. to... Read more